| Product Code: ETC9965200 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) End Stage Renal Disease Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) End Stage Renal Disease Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) End Stage Renal Disease Market - Industry Life Cycle |
3.4 United States (US) End Stage Renal Disease Market - Porter's Five Forces |
3.5 United States (US) End Stage Renal Disease Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) End Stage Renal Disease Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 United States (US) End Stage Renal Disease Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 United States (US) End Stage Renal Disease Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.9 United States (US) End Stage Renal Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) End Stage Renal Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of chronic kidney diseases leading to end-stage renal disease |
4.2.2 Technological advancements in renal replacement therapies |
4.2.3 Growing aging population in the United States |
4.3 Market Restraints |
4.3.1 High cost associated with treatment and management of end-stage renal disease |
4.3.2 Limited availability of organ donors for kidney transplants |
4.3.3 Stringent regulatory requirements in the healthcare industry |
5 United States (US) End Stage Renal Disease Market Trends |
6 United States (US) End Stage Renal Disease Market, By Types |
6.1 United States (US) End Stage Renal Disease Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) End Stage Renal Disease Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) End Stage Renal Disease Market Revenues & Volume, By Calcium Succinate, 2021- 2031F |
6.1.4 United States (US) End Stage Renal Disease Market Revenues & Volume, By Mk-3866, 2021- 2031F |
6.1.5 United States (US) End Stage Renal Disease Market Revenues & Volume, By Pacritinib, 2021- 2031F |
6.1.6 United States (US) End Stage Renal Disease Market Revenues & Volume, By Sanguinate, 2021- 2031F |
6.1.7 United States (US) End Stage Renal Disease Market Revenues & Volume, By Tesidolumab, 2021- 2031F |
6.1.8 United States (US) End Stage Renal Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) End Stage Renal Disease Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 United States (US) End Stage Renal Disease Market Revenues & Volume, By Calcimimetics, 2021- 2031F |
6.2.3 United States (US) End Stage Renal Disease Market Revenues & Volume, By Vitamin D, 2021- 2031F |
6.2.4 United States (US) End Stage Renal Disease Market Revenues & Volume, By Sterols, 2021- 2031F |
6.2.5 United States (US) End Stage Renal Disease Market Revenues & Volume, By Potassium Binders, 2021- 2031F |
6.2.6 United States (US) End Stage Renal Disease Market Revenues & Volume, By Calcium-Based, 2021- 2031F |
6.2.7 United States (US) End Stage Renal Disease Market Revenues & Volume, By Phosphate Binders, 2021- 2031F |
6.3 United States (US) End Stage Renal Disease Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 United States (US) End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, 2021- 2031F |
6.3.3 United States (US) End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperkalaemia, 2021- 2031F |
6.3.4 United States (US) End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, 2021- 2031F |
6.4 United States (US) End Stage Renal Disease Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 United States (US) End Stage Renal Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) End Stage Renal Disease Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 United States (US) End Stage Renal Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 United States (US) End Stage Renal Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) End Stage Renal Disease Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) End Stage Renal Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 United States (US) End Stage Renal Disease Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 United States (US) End Stage Renal Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United States (US) End Stage Renal Disease Market Import-Export Trade Statistics |
7.1 United States (US) End Stage Renal Disease Market Export to Major Countries |
7.2 United States (US) End Stage Renal Disease Market Imports from Major Countries |
8 United States (US) End Stage Renal Disease Market Key Performance Indicators |
8.1 Average wait time for kidney transplants |
8.2 Adoption rate of home dialysis solutions |
8.3 Number of patients on the kidney transplant waiting list |
8.4 Percentage of end-stage renal disease patients receiving preventive care |
8.5 Average life expectancy of end-stage renal disease patients |
9 United States (US) End Stage Renal Disease Market - Opportunity Assessment |
9.1 United States (US) End Stage Renal Disease Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) End Stage Renal Disease Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 United States (US) End Stage Renal Disease Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 United States (US) End Stage Renal Disease Market Opportunity Assessment, By End users, 2021 & 2031F |
9.5 United States (US) End Stage Renal Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) End Stage Renal Disease Market - Competitive Landscape |
10.1 United States (US) End Stage Renal Disease Market Revenue Share, By Companies, 2024 |
10.2 United States (US) End Stage Renal Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here